Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Film Review: The Bourne Legacy

10 September 2012

By Dr Greg Ball

Appeared in BioNews 672

The Bourne Legacy

Directed by Tony Gilroy

The Bourne Legacy sees a return of the Bourne franchise, only this time without its eponymous hero, but rather a whole new breed of biologically enhanced undercover CIA agents. These new agents, in addition to going through the intense physical training that we know well from the previous Bourne films, are experimental subjects in a secret medical program. A leak of this new program is deemed so catastrophic that the CIA decides to shut it down immediately - silencing both the agents and the scientists behind it.

Aaron Cross (Jeremy Renner) is the only agent to survive this shut down, whilst Dr Marta Shearing (Rachel Weisz) is similarly lucky in surviving a mass shooting at the lab where she works for the medical program. Cross seeks out Shearing after realising what is happening and the two go on the run from an increasingly desperate CIA operation headed by Eric Byer (Edward Norton).

So, what of this biological enhancement? What, if any, science is it based on? To begin we know only that the agents have to take two pills - one blue, one green – and collect blood samples to send back to the lab. These pills, rather irritatingly, are continually referred to as 'chems' – surely 'meds' would be more apt? However, we are none the wiser as to what is going on, beyond the regular medical tests and blood samples that the agents have to provide.

It is only after Cross catches up with Dr Shearing that we get an explanation. Dr Shearing is a virologist, and the scientists are using viruses to transfer new DNA into Cross to both physically and mentally enhance him, hence the two pills – one for brains, one for brawn. The physiology behind the enhancements seems fairly shaky (even mitochondria get a mention here) and it is probably unnecessary for the film to delve this deep. However, the viral technology is not as far-fetched as it might sound. The use of viruses to insert DNA, often termed gene therapy, is an active area of research. The technology seeks to hijack the natural property of viruses, namely that of injecting their DNA into a host cell, to transfer new genes into human cells.

This growing area of research focuses on the potential to cure genetic conditions, such as cystic fibrosis, through the insertion of a working copy of the required gene. Progress is such that concerns have already been voiced, during the Olympics, of using this technology for the 'genetic doping' of future athletes. The Bourne Legacy takes this a step further by using the technology to genetically upgrade their undercover agents.

When it finally arrived, I was surprised Dr Shearing's explanation of the science behind the medical program was so detailed. It is refreshing that some of what was alluded to is actually based on fact. We are told fairly accurately that there are two major problems with using viruses for gene therapy - getting the virus into the right cells and then making sure the change induced by the virus lasts.

Predictably for Hollywood we get some fanciful hand waving to overcome these problems. An experiment gone wrong in the 1980s gave researchers the 'map' they needed to target viruses to all the different cells in the body. At least this stands up as a concept, if not being hugely farfetched. The explanation for getting the viral changes to persist however is entirely unsatisfactory and just doesn't stack up. We are told that the pills only produce a temporary effect and that to 'lock in' the enhancement, Cross needs to be infected by live virus and 'viral out'. The whole premise behind the technology is based on using live virus, and so the idea of temporary enhancement being offered by a chemical pill – as the name 'chems' alludes to – doesn't make sense.

This does however provide a good reason for our two heroes to go across the globe in search of this live virus. Unsurprisingly, the live virus is shown to have only minor side effects. A single night of fever and Cross is back to full health and ready to fight off all that the CIA can throw at him.

As far as the movie goes, it is a little light on action compared to the other Bourne movies, but the feel and plot tread a familiar route. Continual references to the absent Jason Bourne in an attempt to link the films together seem misplaced. As a result I spent a fair amount of time trying to remember what happened in those films and if it was relevant to this one, which it isn't. If you hadn't seen the previous ones, the references serve only to confuse and give a sense that you are missing out on something important, which you aren't.

An abrupt ending is somewhat unsatisfactory, leaving many questions unanswered. But it is nice to see that the science crucial to the plot is not pure fantasy and gets an almost positive spin – gene therapy using viruses could lead to medical benefits (although maybe not to create superhuman spies).

SOURCES & REFERENCES

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

20 January 2014 - by Rhys Baker 
This remake of sperm donation film 'Starbuck' touches (too briefly) on several heavy-hitting questions on the ethics of sperm donation...
28 March 2013 - by Michelle Downes 
Lives are torn apart by the misuse of prescription drugs in Steven Soderbergh's 'Side Effects', a twist-filled indictment of the pharmaceutical industry and the US healthcare system...

30 July 2012 - by Dr Rosie Gilchrist 
The European Medicines Agency has recommended European Union market approval for a gene therapy, Glybera, to treat patients with severe cases of a rare genetic condition called lipoprotein lipase deficiency...
16 July 2012 - by Marco Narajos 
Changing Futures is a website developed by young people as a project led by Nowgen. It contains free online resources, delving into cystic fibrosis (CF) and gene therapy, aimed at teenagers and teachers....
02 July 2012 - by Dr Linda Wijlaars 
A gene that codes for nicotine antibodies has been successful in immunising mice against the drug's effects. But although the treatment appears to work in mice, any 'smoking vaccine' is still a long way off...
28 May 2012 - by Dr Victoria Burchell 
As a promotional tool to advertise the research funded by the Wellcome Trust, this short film aims both to enthuse and to inform. In both respects it's relatively successful, combining clear and engaging explanations of two projects with smart graphics and shots of impressive-looking equipment. Unfortunately, a slow and rather confusing start may discourage some viewers from reaching the main messages, all of which are in the second half...
08 May 2012 - by Helen Brooks 
HIV patients treated over a decade ago with genetically modified immune cells have suffered no serious side effects from the treatment. Although the cells may not have been successful in targeting and killing HIV-infected cells, the results are promising as they bolster the safety credentials of gene therapy for clinical use...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation